Stanford Health Care : “I’ve heard of residents using [OpenAI] to guide clinical decision making."

Doctors across the globe are struggling to balance the complex tasks of diagnosing illnesses, providing treatment options, and communicating effectively with patients. However, with the introduction of artificial intelligence chatbots like OpenAI's ChatGPT, doctors seem to have found a way to improve their patients' experiences and even their bedside manner, as detailed in a New York Times article.

Launched in November 2022, ChatGPT has been adopted by numerous medical professionals who believe it can enhance their ability to communicate empathetically with patients. This tool provides doctors the desired compassion and understanding, improving their overall approach. Nevertheless, while some doctors hail ChatGPT as a game-changer, others question its ethics and reliability, according to a Fortune article.

Dr. Gregory Moore, former corporate vice president at Microsoft Health and Life Sciences, praised ChatGPT, stating he wished he had the tool during his training. Dr. Moore found ChatGPT's responses not only accurate but also compassionate, which helped him relay complex medical information to patients, including those with terminal illnesses.

Another example illustrating the potential benefits of ChatGPT is the recent project led by Dr. Michael Pignone, chairman of the department of internal medicine at the University of Texas at Austin. ChatGPT was used to create a script for talking compassionately with patients suffering from alcohol use disorder. The AI chatbot not only provided a helpful and empathetic script but also simplified it to a fifth-grade reading level, making it more accessible to patients with limited medical knowledge.

However, the use of ChatGPT and similar AI chatbots raises concerns among some medical professionals, particularly in regard to ethical and reliability aspects. Dr. Dev Dash, an emergency medicine physician and member of Stanford Health Care's data science team, expressed his reservations, arguing that relying on these tools for clinical decision-making is not appropriate: “I’ve heard of residents using it to guide clinical decision making. I don’t think it’s appropriate.”

Dr. Isaac Kohane, a professor of biomedical informatics at Harvard Medical School, echoes similar concerns, emphasizing the importance of patients' trust in their doctors and the need for physicians to display genuine empathy. While AI chatbots may assist in finding the right words, they might also risk creating a false sense of compassion and understanding.

Moreover, using AI chatbots for better communication might lead to the overreliance on these tools, which could be problematic if incorrect or fabricated information is provided to patients. Doctors might be tempted to use AI chatbots for shortcuts, resulting in scary outcomes in crucial medical situations. Peter Lee, the corporate vice president for research and incubations at Microsoft, shared similar apprehensions.

With the rapid adoption of AI chatbots like ChatGPT comes the need for updated regulations and ethical guidelines. Although AI-powered tools evidently hold the potential to transform the medical industry positively, their reliability and ethical appropriateness must be scrutinized closely.